# A Study Assessing Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise

> **NCT00374907** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 156 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Saxagliptin
- **DRUG:** Placebo
- **DRUG:** Metformin (blinded)
- **DRUG:** Metformin (open-label)

## Key facts

- **NCT ID:** NCT00374907
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2008-01
- **Final completion:** 2009-12
- **Target enrollment:** 156 (ACTUAL)
- **Last updated:** 2015-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00374907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00374907, "A Study Assessing Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00374907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*